Agenda Topics- Cancer Personalised Medicine
- Companion Diagnostics
- Emerging Classes of Biomarkers for MDx
- Emerging technologies in MDx
- MDx for Infectious Diseases
- Next-Generation Sequencing: Its Impact on MDx
- Oncology Biomarkers
Sponsorship and Exhibition OpportunitiesAaron Woodley, Sales & Marketing Manager a.woodley@selectbiosciences.com +44 (0)1787 315129
|
SpeakersLeanna Levine, President, ALine Inc Nicole Pamme, Senior Lecturer, University of Hull Enal Razvi, Biotechnology Analyst, SELECTBIO Steve Blair, Associate Professor and Director, University of Utah Holger Becker, CSO, Microfluidic ChipShop GmbH Elena Schwartz, CSO, Ariadne Diagnostics LLC Vladimir Tolstikov, Core Director, UC Davis Genome Center Mao Mao, Research Fellow, Pfizer Global Research and Development Jan Weile, Project Leader, Institute for Laboratory and Transfusion Medicine at the Heart and Diabetes Centre Robert Yamamoto, Founder, Zova Systems Natasha Paul, Scientific Investigator, TriLink BioTechnologies Jake Strzelecki, Director, Business Development, Biodesix
|